Suriname's Ministry of Health, which published the National Cancer Control Plan 2019 to 2028. The plan says the country has no cancer registry and no national screening programme, and that the government pays for radiotherapy and for treatment in Colombia when care is not available at home.
The National Cancer Control Plan Suriname 2019-2028, with a foreword by the Minister of Health, sets goals for prevention, screening and early detection, diagnosis and treatment, palliative care and surveillance. Its situational analysis says cancer incidence is known only from the pathology department of the Academic Hospital Paramaribo (133 histologically confirmed cases per 100,000 a year in 2013 and 2014), that there is no national cancer registry or screening programme, that radiotherapy was introduced in 2012 and was funded by the government, with patients and insurers not yet charged, and that patients needing services not available in Suriname can be sent to Colombia under a regulation named ARMU-LOV, for which the plan cites a Ministry of Health document of 2004, with treatment and housing at government expense. The Ministry and its Inspectorate set standards and inspect; a steering committee appointed by the Ministry draws up the national medicines list, and a Dutch government guide says a medicine must be on that list to be imported. The Ministry's website says its Registration Committee (Registratiecommissie) assesses medicines before they are admitted to the Surinamese market and keeps the register of packaged medicines. The government's website lists the ministry as the Ministerie van Volksgezondheid, Welzijn & Arbeid. The plan dates from 2019, and OnCo found no published review of its progress. The coordinates are an approximate Paramaribo city point.
Many men in Suriname are diagnosed with prostate cancer when it is already high grade; the authors describe the differences between groups as hypothesis generating.
Most of these women were not being screened as often as WHO advises, and most were not aware of their higher risk.
Most head and neck cancers in Suriname are found late, and the authors call for awareness and earlier detection.
The authors recommend offering an HIV test to every woman diagnosed with cervical precancer or cancer, and starting treatment when it is positive.
It is the baseline that later figures from Suriname are compared with, and it shows how much the count depends on what reaches the one laboratory.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/